로딩 중…
지수 로딩 중…
Prime Medicine, Inc.
PRME· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.23+2.22%
2026-06-18
Price Chart
Prime Medicine, Inc.+79.44%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $583M |
| Revenue | $4M |
| Net Income | $-198M |
| Total Assets | $295M |
| Net Assets | $77M |
| Value | |
| P/B | 7.61x |
| P/S | 144.62x |
| FCF Yield | -27.21% |
| Profitability | |
| ROA | -67.31% |
| Op. Margin | -5121.77% |
| Revenue Growth | -41.13% |
| Financial Health | |
| Debt Ratio | 284.26% |
| Total Debt | $115M |
| FCF | $-159M |
| Cash | $64M |
| Current Ratio | 3.80x |
| Performance | |
| 1Y Return | 79.44% |
| 1M Return | 19.63% |
| From 52W High | -53.46% |
| 1Y MDD | -59.52% |
| Trading | |
| Volume | 3,188,179 shares |
| Trading Value | $10M |
| Per Share | |
| EPS | $-1.35 |
| BPS | $0.81 |